关注
Murali Ramanathan
Murali Ramanathan
Professor of Pharmaceutical Sciences and Neurology
在 buffalo.edu 的电子邮件经过验证 - 首页
标题
引用次数
年份
3d bone microarchitecture modeling and fracture risk prediction
H Li, X Li, L Bone, C Buyea, M Ramanathan, A Zhang
Proceedings of the ACM Conference on Bioinformatics, Computational Biology …, 2012
82012
A computational model for lesion dynamics in multiple sclerosis of the brain
TRK Mohan, S Sen, M Ramanathan
International Journal of Modern Physics E 17 (05), 930-939, 2008
132008
A Computational Model for Lesion Dynamics in Multiple Sclerosis of the Brain
S Sen, M Ramanathan
A Computational Model of Mitigating Disease Spread in Spatial Networks
T Kim, K Li, A Zhang, S Sen, M Ramanathan
International Journal of Artificial Life Research (IJALR) 2 (2), 77-94, 2011
22011
A dispersion model for cellular signal transduction cascades
M Ramanathan
Pharmaceutical research 19, 1544-1548, 2002
92002
A generative framework for prediction and informative risk factor selection of bone diseases
H Li, X Li, Y Zhang, M Ramanathan, A Zhang
2013 IEEE International Conference on Bioinformatics and Biomedicine, 554-559, 2013
52013
A graph-based approach for computational model of bone microstructure
T Kim, M Ramanathan, A Zhang
Proceedings of the First ACM International Conference on Bioinformatics and …, 2010
92010
A hybrid Markov chain–von Mises density model for the drug-dosing interval and drug holiday distributions
K Fellows, V Rodriguez-Cruz, J Covelli, A Droopad, S Alexander, ...
The AAPS Journal 17, 427-437, 2015
102015
A maximum entropy approach to classifying gene array data sets
S Jiang, C Tang, L Zhang, A Zhang, M Ramanathan
Proc. of Workshop on Data mining for genomics, First SIAM International …, 2001
142001
A method for estimating pharmacokinetic risks of concentration-dependent drug interactions from preclinical data
M Ramanathan
Drug Metabolism and disposition 27 (12), 1479-1487, 1999
151999
A multimodal approach to assess the validity of atrophied T2-lesion volume as an MRI marker of disease progression in multiple sclerosis
E Tavazzi, N Bergsland, J Kuhle, D Jakimovski, M Ramanathan, ...
Journal of neurology 267, 802-811, 2020
132020
A network modeling approach for the spatial distribution and structure of bone mineral content
H Li, A Zhang, L Bone, C Buyea, M Ramanathan
The AAPS journal 16, 478-487, 2014
32014
A novel functional module detection algorithm for protein-protein interaction networks
W Hwang, YR Cho, A Zhang, M Ramanathan
Algorithms for Molecular Biology 1, 1-11, 2006
1142006
A Paleolithic Diet-Based Intervention Decreases Multiple Sclerosis Fatigue via Lipid Profile Changes (P2. 358)
M Ramanathan, K Fellows, T Wahls, R Browne, B Bisht, L Snetselaar, ...
Neurology 90 (15 Supplement), 2018
22018
A pharmacokinetic approach for evaluating cytokine binding macromolecules as antagonists
M Ramanathan
Pharmaceutical research 13, 84-90, 1996
81996
A physicochemical modelling approach for estimating the stability of soluble receptor-bound tumour necrosis factor-alpha
M Ramanathan
Cytokine 9 (1), 19-26, 1997
81997
A probabilistic framework to predict protein function from interaction data integrated with semantic knowledge
YR Cho, L Shi, M Ramanathan, A Zhang
BMC bioinformatics 9, 1-15, 2008
182008
A rapid spectrofluorimetric technique for determining drug-serum protein binding suitable for high-throughput screening
HH Parikh, K McElwain, V Balasubramanian, W Leung, D Wong, ...
Pharmaceutical research 17, 632-637, 2000
992000
A semi-supervised learning approach to integrated salient risk features for bone diseases
H Li, X Li, M Ramanathan, A Zhang
Proceedings of the International Conference on Bioinformatics, Computational …, 2013
32013
A stochastic model for optimizing composite predictors based on gene expression profiles
M Ramanathan
Pharmaceutical research 20, 996-1000, 2003
42003
系统目前无法执行此操作,请稍后再试。
文章 1–20